Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
1 CALL ON FILE
ABUS
— Arbutus Biopharma Corp
NASDAQ
FULL STOCK PAGE →
Q3 2024 Earnings Call Summary
NOV 6, 2024
REVENUE
$1.3M
-22.4%
NET MARGIN
-1472.5%
-325.6 PTS
EPS
-$0.10
+9.1%
FREE CASH FLOW
-$20.7M
-43.0%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 1
OLDER CALL →